MicroRNA-Targeted Gene Regulation in Salivary Gland Tissue of De Novo Parkinson's Disease Patients
- PMID: 39467986
- DOI: 10.1007/s12035-024-04581-y
MicroRNA-Targeted Gene Regulation in Salivary Gland Tissue of De Novo Parkinson's Disease Patients
Abstract
Although α-synucleinopathy has been confirmed in the submandibular gland (SMG) tissue of Parkinson's disease (PD) patients, in-depth disease-related molecular research, such as tissue-specific transcriptional signals, has not been performed. In the present study, disease-relevant tissue-specific transcriptional signals in SMG tissue from PD patients were investigated to identify potential diagnostic, prognostic, and pathophysiologic biomarkers. Here, seven de novo drug-naïve PD patients and six age- and sex-matched individuals without neurological or psychological diseases were enrolled. Total RNA sequencing (RNA-seq) and total small RNA-seq (smRNA-seq) were performed on SMG tissue and blood samples, with 26 RNA-seq and 26 smRNA-seq samples used for the final analysis. Differentially expressed genes (DEGs) and microRNAs in SMG tissue and blood from PD patients were obtained and their functional integration and interaction network were analyzed. The Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis revealed that the DEGs interacted with cytokine-, inflammation-, and immune-related pathways. Synphilin-1 expression was significantly downregulated in SMG tissue of PD patients, and α-synuclein expression did not significantly differ between PD patients and controls in either SMG tissue or blood. Fifteen tissue-specific miRNA signals in SMG tissue were identified that showed better diagnostic ability compared with those in blood samples. The correlation between DEGs and environmental factors appeared altered in PD patients. The results indicated the DEGs and microRNA signatures identified in SMG tissue may be promising diagnostic and prognostic biomarkers. These molecular insights offer potential avenues for the development of novel therapeutic strategies targeting the underlying disease mechanisms in PD patients.
Keywords: Biomarker; MicroRNA; Parkinson’s disease; Submandibular gland.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Feasibility of repeat and bilateral submandibular gland needle biopsies in Parkinson's disease.Parkinsonism Relat Disord. 2019 Nov;68:69-72. doi: 10.1016/j.parkreldis.2019.10.006. Epub 2019 Oct 7. Parkinsonism Relat Disord. 2019. PMID: 31621624 Free PMC article.
-
Submandibular gland is a suitable site for alpha synuclein pathology in Parkinson disease.Parkinsonism Relat Disord. 2019 Jan;58:35-39. doi: 10.1016/j.parkreldis.2018.04.019. Epub 2018 Apr 19. Parkinsonism Relat Disord. 2019. PMID: 30340912
-
Integrative analysis of potential biomarkers and immune cell infiltration in Parkinson's disease.Brain Res Bull. 2021 Dec;177:53-63. doi: 10.1016/j.brainresbull.2021.09.010. Epub 2021 Sep 16. Brain Res Bull. 2021. PMID: 34536521
-
[Tandem mass tag-based quantitative proteomics analysis of plasma and plasma exosomes in Parkinson's disease].Se Pu. 2023 Dec;41(12):1073-1083. doi: 10.3724/SP.J.1123.2022.12022. Se Pu. 2023. PMID: 38093537 Free PMC article. Chinese.
-
Expanding the search for genetic biomarkers of Parkinson's disease into the living brain.Neurobiol Dis. 2020 Jul;140:104872. doi: 10.1016/j.nbd.2020.104872. Epub 2020 Apr 14. Neurobiol Dis. 2020. PMID: 32302674 Review.
References
-
- Tolosa E, Garrido A, Scholz SW, Poewe W (2021) Challenges in the diagnosis of Parkinson’s disease. Lancet Neurol 20(5):385–397. https://doi.org/10.1016/S1474-4422(21)00030-2 - DOI - PubMed - PMC
-
- Steiner JA, Quansah E, Brundin P (2018) The concept of alpha-synuclein as a prion-like protein: ten years after. Cell Tissue Res 373(1):161–173. https://doi.org/10.1007/s00441-018-2814-1 - DOI - PubMed
-
- Bartels T, Choi JG (2011) Selkoe DJ (2011) α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature 477(7362):107–110. https://doi.org/10.1038/nature10324 - DOI - PubMed
-
- Conway KA, Lee SJ, Rochet JC, Ding TT, Williamson RE, Lansbury PT Jr (2000) Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson’s disease: implications for pathogenesis and therapy. Proc Natl Acad Sci U S A 97(2):571–576. https://doi.org/10.1073/pnas.97.2.571 - DOI - PubMed
-
- Chahine LM, Beach TG, Brumm MC et al (2020) In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson disease. Neurology 95(9):e1267–e1284. https://doi.org/10.1212/WNL.0000000000010404 - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources